DeepChek® Assay HPV messenger RNA Genotyping (RUO)

The DeepChek® Assay HPV messenger RNA Genotyping a cutting-edge research method that enhances the screening and typing of high-risk human papillomavirus (HPV) infections. This technology not only identifies the presence of HPV but also determines the specific viral strains and assesses the risk of progression to cervical cancer. During research studies, HPV RNA-Seq demonstrated at least equivalent sensitivity compared to gold-standard DNA-based tests, detecting additional HPV-positive cases and multiple infections that were previously unrecognized (https://doi.org/10.1016/j.jmoldx.2019.04.010).

The DeepChek® Assay HPV messenger RNA Genotyping can bring additional information to cytology tests by providing a high sensitivity and possible alternative for HPV monitoring. Its advanced analysis capabilities make it a true game changer for current HPV screening methods. It offers reliable methods for earlier screening and risk assessment, this technology shall be considered for strategies to bring new epidemiological data, to monitor HPV patients and to enhance patient care.